158 related articles for article (PubMed ID: 21088061)
1. Uneasy money: the Instituto Carlos Slim de la Salud, tobacco philanthropy and conflict of interest in global health.
Burch T; Wander N; Collin J
Tob Control; 2010 Dec; 19(6):e1-9. PubMed ID: 21088061
[TBL] [Abstract][Full Text] [Related]
2. Tobacco money and public health.
Collishaw N
Tob Control; 2010 Dec; 19(6):437-8. PubMed ID: 21088062
[No Abstract] [Full Text] [Related]
3. 'Public enemy no. 1': Tobacco industry funding for the AIDS response.
Smith J; Thompson S; Lee K
SAHARA J; 2016; 13(1):41-52. PubMed ID: 27023371
[TBL] [Abstract][Full Text] [Related]
4. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
Tong EK; England L; Glantz SA
Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
[TBL] [Abstract][Full Text] [Related]
5. Conflicts of interest in e-cigarette research: A public good and public interest perspective.
Capps B; van der Eijk Y; Krahn TM
Bioethics; 2020 Jan; 34(1):114-122. PubMed ID: 31448428
[TBL] [Abstract][Full Text] [Related]
6. Examining the sources of evidence in e-cigarette policy recommendations: A citation network analysis of international public health recommendations.
Smith MJ; Baxter AJ; Skivington K; McCann M; Hilton S; Katikireddi SV
PLoS One; 2021; 16(8):e0255604. PubMed ID: 34347823
[TBL] [Abstract][Full Text] [Related]
7. Global health philanthropy and institutional relationships: how should conflicts of interest be addressed?
Stuckler D; Basu S; McKee M
PLoS Med; 2011 Apr; 8(4):e1001020. PubMed ID: 21532739
[TBL] [Abstract][Full Text] [Related]
8. Unhealthy partnerships: the tobacco industry and African American and Latino labor organizations.
Raebeck A; Campbell R; Balbach E
J Immigr Minor Health; 2010 Apr; 12(2):228-33. PubMed ID: 19579065
[TBL] [Abstract][Full Text] [Related]
9. Conflicts of interest in tobacco control in India: an exploratory study.
Rao NV; Bhojani U; Shekar P; Daddi S
Tob Control; 2016 Nov; 25(6):715-718. PubMed ID: 26612763
[TBL] [Abstract][Full Text] [Related]
10. 'It will harm business and increase illicit trade': an evaluation of the relevance, quality and transparency of evidence submitted by transnational tobacco companies to the UK consultation on standardised packaging 2012.
Evans-Reeves KA; Hatchard JL; Gilmore AB
Tob Control; 2015 Jun; 24(e2):e168-77. PubMed ID: 25472733
[TBL] [Abstract][Full Text] [Related]
11. SEATCA Tobacco Industry Interference Index: a tool for measuring implementation of WHO Framework Convention on Tobacco Control Article 5.3.
Assunta M; Dorotheo EU
Tob Control; 2016 May; 25(3):313-8. PubMed ID: 25908597
[TBL] [Abstract][Full Text] [Related]
12. Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.
Weishaar H; Collin J; Smith K; Grüning T; Mandal S; Gilmore A
PLoS Med; 2012; 9(6):e1001249. PubMed ID: 22745607
[TBL] [Abstract][Full Text] [Related]
13. The case for OFSMOKE: how tobacco price regulation is needed to promote the health of markets, government revenue and the public.
Gilmore AB; Branston JR; Sweanor D
Tob Control; 2010 Oct; 19(5):423-30. PubMed ID: 20876078
[TBL] [Abstract][Full Text] [Related]
14. Editorial input for the right price: tobacco industry support for a sheet metal indoor air quality manual.
Campbell R; Balbach E
New Solut; 2013; 23(3):467-83. PubMed ID: 24401484
[TBL] [Abstract][Full Text] [Related]
15. State-ownership of tobacco industry: a 'fundamental conflict of interest' or a 'tremendous opportunity' for tobacco control?
Hogg SL; Hill SE; Collin J
Tob Control; 2016 Jul; 25(4):367-72. PubMed ID: 26243811
[TBL] [Abstract][Full Text] [Related]
16. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
[TBL] [Abstract][Full Text] [Related]
17. The Philip Morris International-Funded Foundation for a Smoke-Free World.
Koh HK; Geller AC
JAMA; 2018 Jul; 320(2):131-132. PubMed ID: 29913010
[No Abstract] [Full Text] [Related]
18. Enacting tobacco taxes by direct popular vote in the United States: lessons from 20 years of experience.
Lum KL; Barnes RL; Glantz SA
Tob Control; 2009 Oct; 18(5):377-86. PubMed ID: 19556615
[TBL] [Abstract][Full Text] [Related]
19. Financial ties and conflicts of interest between pharmaceutical and tobacco companies.
Shamasunder B; Bero L
JAMA; 2002 Aug; 288(6):738-44. PubMed ID: 12169078
[TBL] [Abstract][Full Text] [Related]
20. "A good personal scientific relationship": Philip Morris scientists and the Chulabhorn Research Institute, Bangkok.
Mackenzie R; Collin J
PLoS Med; 2008 Dec; 5(12):1737-48. PubMed ID: 19108600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
